Genmab | GEN - Ordinary Share Capital


Genmab reported DKK61.44M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
Almirall EUR 214.79M 0 Dec/2025
Amarin USD 20.81M 13K Dec/2025
Amgen USD 541M 1000K Jun/2026
argenx SE USD 62.54M 2.74M Jun/2026
AstraZeneca USD 1.55B 44K Jun/2026
Bayer EUR 982.42M 0 Jun/2026
BioMarin Pharmaceutical USD 193.54M 267K Jun/2026
Demant DKK 210.9M 5.18M Dec/2025
Exelixis USD 248.88M 4.82M Jun/2026
Fresenius Medical Care EUR 266.11M 3.98M Jun/2026
Genmab DKK 61.44M 181K Jun/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
GN Store Nord DKK 145.61M 0 Jun/2026
GRIFOLS EUR 680.58M 6K Jun/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Insmed USD 218.28M 1.76M Jun/2026
Lakefront Biotherapeutics EUR 65.66M 242K Jun/2026
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Jun/2026
Novartis USD 1.9B 7.38M Jun/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Sanofi EUR 1.21B 8.25M Mar/2026
UCB EUR 190.36M 365.15K Dec/2025